Home > Newsletters > International Pharmaceutical Regulatory Monitor > Asia Looking to Europe’s HTAs for Guide on Containing Drug Costs
International Pharmaceutical Regulatory Monitor
July 2012 | Vol. 40 No. 7
Asia Looking to Europe’s HTAs for Guide on Containing Drug Costs
PHILADELPHIA – As Taiwan and South Korea increasingly use health technology assessment (HTA) to sift out the costs versus benefits of new drugs, other Asian countries, such as China, are looking at ways to adopt such cost-cutting programs, a pair of recent industry surveys suggests.
ePublishing :: CMS, Hosting & Web Development | © Copyright by FDAnewsAll rights reserved. Do not duplicate or redistribute in any form.